Biosimilars, vaccines and diagnostics CRDMO for human and veterinary use

Biosimilars, vaccines and diagnostics CRDMO for human and veterinary use
Product Description

Yaohai Biotechnology (Beijing) Co.,Ltd

  • CN
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Veterinary Company
Primary activities
Biopharmaceutical
Contract Manufacturer
Specifications

Yaohai Biotechnology (Beijing) Co.,Ltd

  • CN
  • 2016
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Veterinary Company
Primary activities
Biopharmaceutical
Contract Manufacturer

More Products from Yaohai Biotechnology (Beijing) Co.,Ltd (4)

Yaohai Biotechnology (Beijing) Co.,Ltd resources (1)

Frequently Viewed Together

  • Product INJECTABLES

    Requiring injectables.EU-GMP is a must.
    EU dossier is a must.
    Licensing and supply model or distributorship.
  • Product Custom Protein Synthesis

    We provide a Custom Protein Synthesis Service, using a chemical method that synthesises proteins amino acid by amino acid and making modifications on an atomic-scale. We work closely with our partners in designing, customising and optimising the proteins that is synthesized in an automa...
  • Product Kemwell Biopharma

    SERVICES Kemwell provides integrated development and manufacturing services for companies that require one-stop solution for mammalian cell-culture based protein therapeutics The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufa...
  • Product RARE DISEASES & ORPHAN DRUGS

    Lodaat has a portfolio pipeline of Rare Disease and Orphan Drug products.  USFDA in development, we are looking for partners for the US, GCC, LATAM, EU markets.  Many products are made in USA products in FDA approved facilities.
  • Product Ready to use cell lines

    Ready to use cell lines
  • Product Biosimilars Testing Services

    Testing services for biosimilars: Our biosimilar analytical comparability programs provide highly relevant data for early stage characterisation and later stage comparison. These programs evaluate and compare all pertinent features of the biosimilar product and are based on the ICH Q6B. Programs encompa...
  • Product Adjuvant Systems for Vaccines

    We enable next-generation vaccine development through a diverse portfolio of world-leading vaccine adjuvants, immunomodulators and adjuvant formulations.
    We passionately develop new adjuvant technologies and partner to develop the vaccines of tomorrow.
    Our extensive expertise in immunology and fo...
  • Product Humodar B 100R

    PRJSC 'Indar' provides wide range of insulin products in vials and cartridges which includes humodar b 100r. Its an anti-diabetic product of short effect. Ensures quick decrease of glucose level in the blood, intensifies its absorption by tissues. The effect starts after 30 minutes and can last within 5-7 ...
  • Product Crispact®

    Crispact® is a food supplement in stick packs containing the probiotic strain Lactobacillus crispatus M247.

    Each stick pack contains at least 20 billion CFUs(colony forming units) of Lactobacillus crispatusM247, useful for the balance of bacterial flora.

    https://...
  • Product Aseptic fill and finish

    We offer solutions for companies that need CMO capacity concerning the aseptic filling of syringes and assembly and packaging of pre-filled syringes and auto-injectors. We will enhance your product by adding value through manufacturing if you require additional capacity or a complete technology transfer. q...
  • Product Pipeline

    Polpharma Biologics has its own pipeline of biosimilars for out-licensing.
    We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars.
  • Product NEOANTIGEN PEPTIDES

    Our Peptide-based Personalised Medicine Laboratory (PPM Lab) has been designed and equipped with state-of-the-art technology to meet the unique requirements of neoantigens production. A dedicated and experienced team of chemists and doctors ensures full control of the processes.

    The implementati...
  • Product HANLIKANG (Rituximab Injection)

    HANLIKANG (rituximab injection) is the company's first proprietary product. It is the first-ever China-manufactured biosimilar approved by the NMPA in accordance with the Technical Guideline for the Development and Evaluation of Biosimilars (Tentative) issued in 2015. As of now, HANLIKANG has bee...
  • Product Eylea biosimilar vial & PFS

    1.Completion of global clinical trials phase Ⅲ 
    2. Completion of pre-submission meetings with advanced regulatory authorities
    3. Available in Vial and PFS
  • Product CDMO: Contract Manufacturing

    EVER Pharma is a specialist in the manufacture of complex injectable products such as low oxygen formulations, crystal suspensions and oily solutions. This includes many highly active substances such as narcotics, hormones and cytotoxics.

    Our state-of-the-art facility utilizes the latest innovatio...
  • Product Pharmatec GmbH Vaccine Manufacturing Line

    NEW/NEVER USEDIMMEDIATELY AVAILABLE FROM A CANCELLED PROJECT Complete Pilot Size Vaccine Development Manufacturing Lines  Manufacturer: Syntegon Pharmatec GmbH/Germany - 2021

    - Pressure Equipment Directive (PED) 2014/68/EU- European GMP (Good Manufacturing Practice) Directives- Vessels pass...
  • Product Rituximab

    Rituximab binds itself to the CD20 protein, marking them, and subsequently triggering the cells of the immune system to pick out the marked cells and kill them.The indication is for Non Hodgkin Lymphoma
  • Product AB-PROTEARS®

    AB-PROTEARS® is a next-generation eye drop formula designed to address dry eyes, allergies, and inflammation. Powered by the paraprobiotic Lysate L. sakei proBio 65, it works by restoring balance to the ocular microbiome, reducing inflammation, and providing long-lasting relief from irritation. Its antioxi...
  • Product Biosimilars Portfolio

    • Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...
  • Product Anakinra Biosimilar Candidate

    Paras Biopharmaceuticals has been intensively working on a Anakinra / IL1-RA biosimilar known as Kineret™) and has progressively achieved success. The company plans to mature good value within its Anakrina / IL1-RA asset and would like to highlight the following points / highlights to gauge your level of ...
  • Product Pharmaceutical and Biological Products Contract Development and Manufact...

    Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO). Our six state-of-the-art cGMP manufacturing facilities across Asia and North America deliver to more than 100 markets around the world. Our sites have the highest industry standards for quality, dev...
  • Product Remsima

    The world's 1st mAb biosimilar • Ingredient: Infliximab • Indication: Rheumatoid arthritis, inflammatory bowel disease • Mode of mechanism: Relieves disease progression by inducing a neutralizing response to tumor necrosis factor(TNF-α), the cause of autoimmune disease • Approval status: 100 countri...
  • Product ULC Series 328

    FARRAR® pioneered forced air convection cooling to answer the challenge of preserving and storing biological and human tissue donor samples and materials. Purpose-built for life science applications, the Ultra-Low Chamber ULC-190, ULC-259, and ULC-328 are the only -20°C to-80°C, forced air, ultra-low-t...
  • Product Biologics

    End-to-end development and manufacturing capabilities across different therapeutic modalities and the entire product lifecycle

    Cutting-edge technology platforms for high yielding cell lines (both mammalian and microbial) and high concentration formulations


    Integrated and flexible drug sub...
  • Product Method Development

    We are specialist in the method development of analytical methods for analysis of API, Final Drug Products or low level impurities. Usually followed by full validation in accordance to ICH guidelines.
  • Product Interview by Newsweek, time to talk

    Interviewee:Dr. Steve J.P. Hsu (President of Genovior Biotech)
  • Product TIM-2

    The TIM-2, as part of the SurroGUT™ platform, is the dynamic in vitro model of the large intestine. The lower GI model, with its anaerobic compartment containing highly metabolic active intestinal microbiota, precisely mimics the physiological conditions of the colon in vivo. TIM-2 can simulate the pr...
  • Product Sterile Fill Finish

    Our facility was purpose-built to meet increasing market demand for shorter sterile drug product development timelines, while consistently maintaining regulatory compliance.
    Today, we reliably support our customers with the aseptic filling and lyophilization of conventional, biologic a...
  • Product Format Change Parts for Pharmaceutical Filling Machines

    Manufactured from Plastics as: Delrin (Pom-C), Arnite (Ertalyte), Polyethylene, Peek or from Steels: AISI 316L – AISI 304 – AISI 303 - All types can be produced: Stars, Sectors, Guides, Combs, Joints, Loading and Unloading Screws etc - Super Finishing on Plastic Materials Polished, Satined or Sandblasted S...
  • Product Drug Product Fill-Finish Services

    Fill-Finish Capabilities (product type) and Capacity:
    Sterile liquid products
    Biosafety level (BSL) 1, BSL 2 (OEL >= 10 µg/m³)
    Vaccines (inactivated)
    Current capacity: ~40M units/year
  • Product Recombinant Ebola Virus Disease Vaccine (Adenovirus Type 5 Vector)

    Asia's first and World's third Ebola virus disease vaccine

    The only one approved for emergency use and national stockpile in China

  • Product Purelium pearls

    Patented precise micro units of active ingredients in an enhanced oil-based matrix, sealed in a solid crust for enhanced pharmaceutical and nutraceutical capsule formulation.For more infmrmation please visit www.purelium.com
  • Product 5th Generation Prefilled Syringe

    This innovative medical device is the newly patented 5th generation of prefilled syringes. Its innovative design overtakes the weak points of standard pfs, particularly by eliminating the break-loose force and any need for silicone oil. 

    The absence of silicone oil makes it the pe...
  • Product Ampoules Filling and Sealing - RSF Series

    The filling and sealing machines RSF are suitable for aseptic dosing of liquid products and sealing of open or closed ampoules.
    As an option, RSF machines can be used for filling and rubber stoppering of vials.

    Main features:

    - Perfect operational repeatability;- Comp...
  • Product 23-valent Pneumococcal Polysaccharide Vaccine

    To prevent invasive diseases caused by 23 serotypes of Streptococcus pneumoniae for use in individuals aged ≥ 2 years who are at increased risk of pneumococcal diseases
  • Product DecFill® Aseptic Filling Solutions

    DecFill® solutions are configured to meet a wide range of product and customer requirements. These include de-bagging, de-lidding and de-nesting units and various other options to accurately fill liquids, powders and gels into the various containers.To ensure highest process performance within a controlled...
  • Product Prefilled Syringes & Injection Devices - October 2023 - Issue 152

    Available now to read online at: https://www.ondrugdelivery.com Contents: An Autoinjector Revolution: Enhanced Global Manufacturing NetworksThrough Advanced Simulation Technologies SHL Medical Identifying and Overcoming the Challenges ofInjectable Combination Product Evolution Kindeva Interview – Acce...